Are cellular polarisation and mitotic frequency prognostic factors for local recurrence in patients with ductal carcinoma in situ of the breast?

European Journal of Cancer

Volumn 39, Issue 12, 2003, Pages 1704-1710

  Idvall, I ^a,b   Anderson, H ^a   Ringberg, A ^a   Ferno M ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b HELSINGBORG HOSPITAL   (Sweden)

Author keywords

Breast cancer; Cellular polarisation; Ductal carcinoma in situ; Local recurrence; Mitotic frequency; Nuclear grade

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADULT; AGED; ARTICLE; BREAST DUCT IN SITU CARCINOMA; CANCER RECURRENCE; CARCINOMA IN SITU; CELL POLARITY; CONSERVATIVE TREATMENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS RATE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0042347742     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(03)00395-2     Document Type: Article

References (17)

1. Lagios M.D. Duct carcinoma in situ. pathology and treatment Surg. Clin. North Am. 70:1990;853-871.
2. Lagios M.D., Margolin F.R., Westdahl P.R., Rose M.R. Mammographically detected duct carcinoma in situ. Frequency of local recurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer. 63:1989;618-624.
3. Solin L.J., Yeh I.T., Kurtz J.et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breastconserving surgery and definitive irradiation. Correlation of pathological parameters with outcome of treatment. Cancer. 71:1993;2532-2542.
4. Ringberg A., Idvall I., Fernö M.et al. Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast. Eur. J. Surg. Oncol. 26:2000;444-451.
5. Holland R., Peterse J.L., Millis R.R.et al. Ductal carcinoma in situ. a proposal for a new classification Semin. Diagn. Pathol. 11:1994;167-180.
6. Silverstein M.J., Poller D.N., Waisman J.R.et al. Prognostic classification of breast ductal carcinoma - in-situ. Lancet. 345:1995;1154-1157.
7. Wärnberg F., Nordgren H., Bergh J., Holmberg L. Ductal carcinoma in situ of the breast from a population-defined cohort. an evaluation of new histopathological classification systems Eur. J. Cancer. 35:1999;714-720.
8. Elston C.W. Grading of invasive carcinoma of the breast. Page D., Anderson T.J. Diagnostic histopathology of the breast. 1987;300-311 Churchill Livingstone, Edinburgh, London, Melbourne, New York.
9. Elston C.W., Ellis I.O. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer. experience from a large study with long-term follow-up Histopathol. 19:1991;403-410.
10. Contesso G., Mouriesse H., Friedman S., Genin J., Sarrazin D., Rouesse J. The importance of histologic grade in long-term prognosis of breast cancer. a study of 1010 patients, uniformly treated at the Institute Gustave-Roussy J. Clin. Oncol. 5:1987;1378-1386.
11. Simpson J.F., Dutt P.L., Page D.L. Expression of mitosis per thousand cells and cell density in breast carcinomas. a proposal Hum. Pathol. 23:1992;608-611.
12. Sloane J.P., Amendoeira I., Apostolikas N.et al. Consistency achieved by 23 European pathologists in categorising ductal carcinoma in situ of the breast using five classifications. Hum. Pathol. 29:1998;1056-1062.
13. Ringberg A., Anagnostaki L., Anderson H.et al. Cell biological factors in ductal carcinoma in situ (DCIS) of the breast-relationship to ipsilateral local recurrence and histopathological characteristics. Eur. J. Cancer. 37:2001;1514-1522.
14. Baak J.P.A., Van Dop H., Kurver P.H.J.et al. The value of morphometry to classic prognosticators in breast cancer. Cancer. 56:1985;374-385.
15. Baak J.P.A. Mitosis counting in tumours. Human Pathol. 21:1990;683-685. (editorial).
16. Badve S., ÁHern R.P., Ward A.M.et al. Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications. a comparative study with long follow-up Hum. Pathol. 29:1998;915-923.
17. Wells W.A., Carney P.A., Eliassen M.S., Grove M.R., Tosteson A.N.A. Pathologistś agreement with experts and reproducibility of breast ductal carcinoma-in-situ classification schemes. Am. J. Surg. Pathol. 24:2000;651-659.